Corundum Trust Company, Inc Merck & Co., Inc. Transaction History
Corundum Trust Company, Inc
- $34.4 Billion
- Q2 2024
A detailed history of Corundum Trust Company, Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Corundum Trust Company, Inc holds 1,982 shares of MRK stock, worth $215,225. This represents 0.71% of its overall portfolio holdings.
Number of Shares
1,982
Previous 2,835
30.09%
Holding current value
$215,225
Previous $292 Million
15.93%
% of portfolio
0.71%
Previous 0.87%
Shares
3 transactions
Others Institutions Holding MRK
# of Institutions
3,826Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$26.6 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$22.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$12.8 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.87 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.19 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $275B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...